EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
about
EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
EPHB6 augments both developmen ...... egative breast cancer tumours.
@en
EPHB6 augments both developmen ...... egative breast cancer tumours.
@nl
type
label
EPHB6 augments both developmen ...... egative breast cancer tumours.
@en
EPHB6 augments both developmen ...... egative breast cancer tumours.
@nl
prefLabel
EPHB6 augments both developmen ...... egative breast cancer tumours.
@en
EPHB6 augments both developmen ...... egative breast cancer tumours.
@nl
P2093
P2860
P1433
P1476
EPHB6 augments both developmen ...... egative breast cancer tumours.
@en
P2093
Alana L Welm
Amanda Gall
Amr El Zawily
Andrew Freywald
Behzad M Toosi
C Ronald Geyer
Darrell Mousseau
Deborah H Anderson
Franco J Vizeacoumar
Frederick S Vizeacoumar
P2860
P2888
P356
10.1038/S41388-018-0228-X
P407
P577
2018-04-27T00:00:00Z